BRIEF published on 01/19/2026 at 10:05, 19 days 18 hours ago Medios AG Enters Medicinal Cannabis Market European Market Medios AG Pharmaceutical Distribution Medicinal Cannabis Bedrocan Partnership
PRESS RELEASE published on 01/19/2026 at 10:00, 19 days 18 hours ago Medios AG enters market for medicinal cannabis Medios AG expands into medicinal cannabis market with exclusive distribution rights for Bedrocan products in Europe, strengthening expertise in oncology and neurology Pharmaceuticals Oncology Medios AG Medicinal Cannabis Bedrocan
BRIEF published on 11/11/2025 at 07:29, 2 months 26 days ago Medios AG Reports Robust Earnings Growth in Early 2025 EBITDA Revenue Growth Financial Performance Pharmaceuticals Medios AG
PRESS RELEASE published on 11/11/2025 at 07:24, 2 months 26 days ago Medios AG achieves strong growth in earnings and profit margin in the first nine months of 2025 Medios AG achieves 9.2% revenue growth and 26.1% increase in EBITDA pre1 in the first nine months of 2025. New CEO appointed. Outlook confirmed. Details in press release EBITDA Revenue Growth CEO Appointment Medios AG 2025 Outlook
BRIEF published on 11/03/2025 at 10:02, 3 months 4 days ago Thomas Meier Appointed CEO of Medios AG Growth Strategy CEO Appointment Medios AG Specialty Pharma Thomas Meier
PRESS RELEASE published on 11/03/2025 at 09:57, 3 months 4 days ago Thomas Meier becomes new CEO of Medios AG Thomas Meier appointed as new CEO of Medios AG effective February 1, 2026, succeeding Matthias Gaertner. Meier's past roles include CEO of Bachem Holding AG. Medios AG aims for further growth under his leadership CEO Appointment Medios AG Specialty Pharma Thomas Meier Bachem Holding AG
BRIEF published on 10/24/2025 at 11:09, 3 months 14 days ago Medios AG: Reallocation of Bencis Shares Medios AG Specialty Pharma Share Reallocation Bencis Capital Partners Janus Henderson Group
PRESS RELEASE published on 10/24/2025 at 11:04, 3 months 14 days ago Medios AG: Reallocation of Bencis shares Medios AG announces reallocation of Bencis shares to Janus Henderson, representing approximately 6.7% of share capital. Bencis sold shares acquired in 2024 through capital increase related to Ceban Pharmaceuticals B.V Janus Henderson Medios AG Specialty Pharma Bencis Shares Individualized Medicine
BRIEF published on 08/13/2025 at 07:42, 5 months 25 days ago Medios AG Reports Strong Growth in H1 2025 Revenue Growth Medios AG EBITDA Increase H1 2025 Pharmaceutical Segments
PRESS RELEASE published on 08/13/2025 at 07:37, 5 months 25 days ago Medios accelerates growth in the first half of 2025 and significantly increases earnings Medios accelerates growth in the first half of 2025, with revenue up by 9.3% to €991.7 million and EBITDA significantly increasing by 48.8%. Successful share buyback. Positive outlook for 2025 EBITDA Revenue Outlook Growth Medios
Published on 02/07/2026 at 01:00, 1 day 3 hours ago Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 1 day 5 hours ago Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Published on 02/06/2026 at 22:01, 1 day 6 hours ago Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan
Published on 02/06/2026 at 15:30, 1 day 13 hours ago Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 02/06/2026 at 13:30, 1 day 15 hours ago Redwood AI Corp. (formerly Marshall Technologies Corp.) Announces Closing of IPO and Listing of Shares on the Canadian Securities Exchange
Published on 02/07/2026 at 21:00, 7 hours 58 minutes ago Alibaba Group Debuts 'Wonder on Ice,' an Immersive AI Experience at Milan’s Sforza Castle for Milano Cortina 2026
Published on 02/07/2026 at 16:35, 12 hours 23 minutes ago The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies
Published on 02/07/2026 at 16:20, 12 hours 38 minutes ago NOTICE OF SETTLEMENT APPROVAL HEARING - SHORT FORM - WAYLAND GROUP CORP., SCOTT LANGILLE, GERHARD MÜLLER, PAUL PATHAK, ERIC SILVER, MICHAEL STEIN, JOHN DOES 1-3, CANACCORD GENUITY CORP., AND RF SECURITIES CLEARING LP (FORMERLY KNOWN AS GMP SECU
Published on 02/06/2026 at 19:25, 1 day 9 hours ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/06/2026 at 17:52, 1 day 11 hours ago EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG
Published on 02/06/2026 at 18:22, 1 day 10 hours ago Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 1 day 12 hours ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/05/2026 at 18:06, 2 days 10 hours ago Aéroports de Paris SA - Shares and voting rights as of 31 January 2026
